News

In recent articles, Mayo Clinic Laboratories emphasizes the transformative potential of recognizing and leveraging the capabilities of a hospital laboratory. With more touchpoints than any other outpatient service line, the laboratory is full of opportunity to enhance local healthcare delivery and bolster a hospital’s financial stability.

Join Mayo Clinic Laboratories at the American Academy of Neurology Annual Meeting 2024.

William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, is a contributing author on Nasdaq.com. In his latest article, he describes the untapped potential of hospital laboratories and how health systems can maximize the value of their labs.

Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, joins “Becker’s Healthcare Podcast” to discuss organizational alignment during times of change. She shares her expertise on creating transparency, fostering open communication, and using data to stay on track with business goals.

William Morice II, M.D., Ph.D., president and chief executive officer of Mayo Clinic Laboratories, is a contributing author on Nasdaq.com. In his first article, Dr. Morice reflects on the diagnostic landscape and predicts trends that could influence the market in 2024.

A winter storm is occurring in the Northeast which may impact specimen transport. The winter storm is expected to spread snow, strong winds, and create possible blizzard conditions which could impact courier pickups and route delays. We are monitoring the situation and will implement contingency plans as needed to avoid any potential delays. Clients should expect to be contacted directly by the couriers should any routes be modified or canceled. 

Mayo Clinic Laboratories now offers the first preeclampsia-specific test (Mayo ID: PERA) that can be used to stratify patients into low or high-risk categories, indicating whether a patient is at risk for developing preeclampsia with severe features. With this information, clinicians can make more informed decisions about hospitalization, monitoring, more frequent checkups, and even early delivery.

Due to a major weather impact at the FedEx hub in Memphis, Tennessee, the Mayo Clinic Laboratories’ Global Logistics team is working to minimize any client impacts. Please visit our website for updates. For any immediate needs, please contact Customer Service at 800-533-1710 and ask to be forwarded to the Global Logistics specialist. 

Globally, five million deaths are associated with bacterial antimicrobial resistance each year, but the complexity of the issue is there is no single solution because we need to use antibiotics. It’s about finding a different way to live with it.

There is a major weather system moving across the United States that may impact specimen transport. Winter storm Finn is expected to spread snow, strong winds, and create possible blizzard conditions into the Plains and Midwest. This may impact courier pickups and cause delays at major hubs (Fed Ex and UPS). We are monitoring and tracking this situation with our logistics partners and are prepared to adjust to minimize challenges. Clients should expect to be contacted directly by the couriers should any routes be modified or canceled.

Mayo Clinic Laboratories is excited to announce our participation in Medlab Middle East 2024, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 5–8, 2024.

Mayo Clinic Laboratories is grateful for the opportunity to serve you and other healthcare professionals around the globe in providing critical answers and actionable insights.

The United States will observe the New Year holiday on Monday, Jan. 1. On this day, Mayo Clinic Laboratories will be open; however, specimen shipments and deliveries to our laboratories will not be made by the carriers. To safeguard specimens, please follow these shipping recommendations.